title: Cytomegalovirus-associated meningoradiculoneuritis after treatment of mantle cell lymphoma with a combination of chemotherapy and rituximab.
authors.forename: S
authors.initials: S
authors.lastname: Vallet
authors.forename: A
authors.initials: A
authors.lastname: Tempescul
authors.forename: A
authors.initials: A
authors.lastname: Tran
authors.forename: M C
authors.initials: MC
authors.lastname: Legrand-Quillien
authors.forename: V
authors.initials: V
authors.lastname: Narbonne
authors.forename: C
authors.initials: C
authors.lastname: Berthou
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000209:etiology; D006801:Humans; D016867:Immunocompromised Host; D020522:Lymphoma, Mantle-Cell / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008587:Meningitis, Viral / Q000150:complications* / Q000175:diagnosis; D008875:Middle Aged; D011843:Radiculopathy / Q000175:diagnosis / Q000209:etiology*; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab